HIGHER ENDOSCOPIC AND CLINICAL REMISSION RATES WITH VEDOLIZUMAB IN EARLY THAN IN LATE CROHN’S DISEASE: RESULTS FROM THE LOVE-CD STUDY (LOW COUNTRIES VEDOLIZUMAB IN CD STUDY)

Geert R. D'Haens  1     Peter Bossuyt  2     Filip Baert  3     Tamás Molnár  4     Wouter Van Moerkercke  5     Esmee Clasquin  1     Mark Lowenberg  6     Nahid Mostafavi  6     Harald Peeters  7     Guy Lambrecht  8     Frank Hoentjen  9     Severine Vermeire  10    
1 Amsterdam University Medical Centers, Amsterdam, Netherlands
2 Imelda General Hospital, Bonheiden, Belgium
3 Az Delta, Roeselare, Belgium
4 University Of Szeged, Szeged, Hungary
5 AZ Groeninge, Kortrijk, Belarus
6 Amsterdam University Medical Center, Amsterdam, Netherlands
7 St Lukas Hospital, Gent, Belgium
8 MSD, Oostende, Belgium
9 Radboud University Medical Center, Nijmegen, Netherlands
10 University Hospital Leuven, Leuven, Belgium

Topic
IBD, Nurses, Primary Care

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing